Proactive Investors - Run By Investors For Investors

Cellmid 'on track for record revenues' in FY19, targeting profitability in FY20

Cellmid Limited (ASX:CDY) CEO Maria Halasz tells Proactive Investors the major achievements since raising $10 million in September last year, and details the next phases of growth.

Cellmid is a life sciences company with a consumer business that has consistently delivered double digit revenue growth and is heading towards profitability. It is also the owner and developer of the largest intellectual property portfolio around midkine; a drug target indicated in cancer, inflammatory diseases and fibrosis.

 
Meet Yellow Cake PLC, Avation PLC, Manolete Partners PLC and Crossword Cybersecurity Plc at our event, London , 05 September 2019. Register here »
View full CDY profile View Profile

Cellmid Ltd Timeline

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use